Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease

被引:18
|
作者
Khan, Hassan [1 ]
Anker, Stefan D. [2 ,3 ]
Januzzi, James L., Jr. [4 ]
McGuire, Darren K. [5 ]
Sattar, Naveed [6 ]
Woerle, Hans Juergen [7 ]
Butler, Javed [8 ]
机构
[1] Emory Univ, Cardiol Div, Atlanta, GA 30322 USA
[2] Charite, Dept Cardiol CVK, Heart Failure Cachexia & Sarcopenia, Div Cardiol & Metab, Berlin, Germany
[3] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany
[4] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA
[6] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[7] Boehringer Ingelheim Pharma & Co KG, Ingelheim, Germany
[8] SUNY Stony Brook, Cardiol Div, Stony Brook, NY 11794 USA
基金
美国国家卫生研究院;
关键词
Heart failure; diabetes mellitus; epidemiology; outcomes; mortality; hospitalization; ejection fraction; RISK-FACTORS; HEALTH; DYSFUNCTION; OUTCOMES; MARKERS; UPDATE; ADULTS;
D O I
10.1016/j.cardfail.2018.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Epidemiology of patients with comorbid heart failure (HF) and diabetes mellitus (DM) without coronary heart disease (CHD) is not well described. Methods and Results: We assessed HF incidence and outcomes in 2896 participants of the Health ABC Study (age 74.0 +/- 3.0 years, 48.4% men, 41.1% black, 34.6% with DM) in relation to prio DM and CHD status. During a median follow-up of 11.4 years, 484 participants (16.7%) developed incident HF; 214 (44.2%) had DM of whom 71 (33.1%) had no prio CHD. Incident HF rate was 2.5% per 100 person-years in those with and 1.5% in those without DM (hazard ratio [HR] 1.66, 95% CI 1.39-1.99). In those with DM, incident HF rate was 4.6% in those with and 1.3% in those without CHD (HR 3.75, 95% CI 2.81-4.99). During a median follow-up of 2.1 years after HF onset, 329 (68.0%) of the participants died. Amongst those with DM, annual mortality was 22.6% in those with versus 25.9% without CHD (HR 0.86, 95% CI 0.61-1.22). All-cause hospitalizations after incident HF in DM patients were 55.0 per 100 person years in those with and 33.3 in those without CHD (rate ratio [RR] 1.64, 95% CI 1.24-2.16); HF hospitalizations were 42.7 and 30.7 per 100-person years (RR 1.39, 95% CI 1.03-1.86) in those with and without CHD. Reduced ejection fraction was seen in 49.6% of HF patients with DM and CHD and in 34.7% of those without CHD (P = .08); mortality but not hospitalization risk tended to be lower in those with reduced compared with preserved ejection fraction regardless of CHD status. Conclusions: A sizeable proportion of HF in patients with DM develops in the absence of prior CHD; these patients are at risk for mortality similar to those with CHD. These data underscore the importance of modulating risk beyond atherosclerosis in patients with comorbid HF and DM.
引用
收藏
页码:78 / 86
页数:9
相关论文
共 50 条
  • [31] Management of Heart Failure in Patients With Diabetes Mellitus in the UAE: A Call to Action
    Sabbour, Hani
    Ahmad, Aftab
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 28
  • [32] Metformin in patients with type 2 diabetes mellitus and heart failure: a review
    Kulaczkowska, Zofia M.
    Wrobel, Marta
    Rokicka, Dominika
    Gasior, Mariusz
    Strojek, Krzysztof
    ENDOKRYNOLOGIA POLSKA, 2021, 72 (02) : 163 - 170
  • [33] Sudden cardiac death in patients with diabetes mellitus and chronic heart failure
    Walker, Andrew M. N.
    Cubbon, Richard M.
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (04): : 228 - 233
  • [34] Heart failure and diabetes mellitus: Epidemiology and management of an alarming association
    Cohen-Solal, Alain
    Beauvais, Florence
    Logeart, Damien
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (07) : 615 - 625
  • [35] Epidemiology of Heart Failure in Europe
    Maggioni, Aldo Pietro
    HEART FAILURE CLINICS, 2015, 11 (04) : 625 - +
  • [36] Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
    Theofilis, Panagiotis
    Oikonomou, Evangelos
    Tsioufis, Konstantinos
    Tousoulis, Dimitris
    LIFE-BASEL, 2023, 13 (02):
  • [37] Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
    Filippatos, Gerasimos
    Butler, Javed
    Farmakis, Dimitrios
    Zannad, Faiez
    Ofstad, Anne Pernille
    Ferreira, Joao Pedro
    Green, Jennifer B.
    Rosenstock, Julio
    Schnaidt, Sven
    Brueckmann, Martina
    Pocock, Stuart J.
    Packer, Milton
    Anker, Stefan D.
    CIRCULATION, 2022, 146 (09) : 676 - 686
  • [38] Diabetes mellitus and heart disease
    Ambhore, Anand
    Teo, Swee Guan
    Poh, Kian Keong
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (07) : 370 - 376
  • [39] Arterial Hypertension in Patients with Heart Failure
    Diez, Javier
    HEART FAILURE CLINICS, 2014, 10 (02) : 233 - +
  • [40] Diabetes Mellitus in Advanced Heart Failure
    Dunlay, Shannon M.
    Killian, Jill M.
    Mccoy, Rozalina G.
    Redfield, Margaret M.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (03) : 503 - 508